B. A. Harder

GMP-Beanstandungen bei Inspektionen von pharmazeutischen Herstellbetrieben in den USA, in Europa und in der Schweiz : Schwerpunkt: Validierung/Qualifizierung : Pharmazeutische qualitätssicherung

B. A. Harder, H. Siegrist, J. Wiederkehr, 1999 .

Triiodothyronine restricts myofibrillar growth and enhances beating frequency in cultured adult rat cardiomyocytes

B. A. Harder, H. Eppenberger, M. Hefti, 1998, Basic Research in Cardiology.

Signaling pathways in cardiac myocyte hypertrophy.

B. A. Harder, H. Eppenberger, M. Hefti, 1997, Journal of molecular and cellular cardiology.

Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes

B. A. Harder, H. Eppenberger, M. Hefti, 1997, Journal of Molecular Medicine.

Differential protein localization in sarcomeric and nonsarcomeric contractile structures of cultured cardiomyocytes.

B. A. Harder, H. Eppenberger, M. Hefti, 1998, Journal of structural biology.

Triiodothyronine induces over-expression of alpha-smooth muscle actin, restricts myofibrillar expansion and is permissive for the action of basic fibroblast growth factor and insulin-like growth factor I in adult rat cardiomyocytes.

B. A. Harder, H. Eppenberger, M. Schaub, 1996, The Journal of clinical investigation.

Myosin filament structure in vertebrate smooth muscle

B. A. Harder, J. Gillis, P. Uman, 1996, The Journal of cell biology.

Influence of fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-I) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular cardiomyocytes in culture.

B. A. Harder, H. Eppenberger, M. Schaub, 1996, Journal of molecular and cellular cardiology.